Black Cohosh Appears Safe, but May Not Benefit Women With PCOS-Related Infertility
Black cohosh is a natural phytoestrogen product occasionally used in the management of PCOS-related infertility.
Complementary and Alternative Medicine
FDA Cracks Down on Companies Selling Unapproved CBD Products
The products described in the warning letters are being marketed as topical pain therapies, though none have actually been evaluated by the FDA.
Valerian Quality, Storage Issues May Affect Sleep Outcomes
While valerian is considered a popular herbal supplement for managing sleep disorders, study outcomes related to its effectiveness have been inconsistent.
Complementary, Alternative Medicine Use Increasing for MS
Ninefold increase observed in likelihood of patients speaking to their neurologist about CAM use.
Pre/Probiotics May Be Useful for Depression, Anxiety
All seven studies demonstrated significant improvements in one or more of the outcomes measured
Supplements With Undeclared Active Ingredients Pose Substantial Health Risk
A recent Morbidity and Mortality Weekly Report (MMWR) highlights the risks associated with use of over-the-counter (OTC) products containing undeclared prescription ingredients as well as the importance of collaboration between various health departments and systems to ensure a prompt response to an outbreak.
Warning Letters Issued to Several Companies Selling Unapproved “Homeopathic” Injectables
The FDA has issued warning letters to several companies selling unapproved injectable products labeled as homeopathic.
‘Dead’ Probiotic Treatment May Help Reduce Irritable Bowel Symptoms
Significantly more patients receiving nonviable probiotic vs placebo had relief of IBS symptoms.
FDA, FTC Crack Down on Fraudulent COVID-19 “Treatments”
Warning letters issued by the FDA and the Federal Trade Commission (FTC) have been sent to several companies selling fraudulent products claiming to treat or prevent coronavirus 2019 (COVID-19).
Adding Curcumin to Mesalamine May Benefit Patients With Ulcerative Colitis
“Given the minimal adverse events, we recommend that curcumin be considered as an adjunct to mesalamine in the treatment of UC.”
